Catalyst Wire Dossier Catalyst Wire Dossier

MD-1100 Acetate

tenapanor · Ironwood Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MD-1100 Acetate, covering 2006-10-20 to 2009-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation [Phase 2]

See pricing